temozolomide has been researched along with 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gescher, A; Quarterman, CP; Slack, JA; Tsang, LL | 1 |
| Andrasi, M; Bustos, R; Gaspar, A; Gomez, FA; Klekner, A | 1 |
2 other study(ies) available for temozolomide and 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide
| Article | Year |
|---|---|
Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide.
Topics: Animals; Antineoplastic Agents; Cell Division; Chromatography, High Pressure Liquid; Dacarbazine; Lymphoma; Mice; Prodrugs; Temozolomide; Tumor Cells, Cultured | 1991 |
Analysis and stability study of temozolomide using capillary electrophoresis.
Topics: Aminoimidazole Carboxamide; Antineoplastic Agents, Alkylating; Chromatography, Micellar Electrokinetic Capillary; Dacarbazine; Drug Stability; Half-Life; Humans; Hydrogen-Ion Concentration; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Temozolomide; Temperature; Water | 2010 |